Anticipated Release Date: Q2 FY27 Next-generation CBRN resilience initiative aimed at delivering threat agnostic host directed medical countermeasures that enhance the body’s ability to withstand, mitigate, and recover from the complex and overlapping physiological impacts Read More
Anticipated Release Date: Q4 FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous solicitations throughout the year, so even Read More
Anticipated Release Date: Q4 2027 This opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous opportunities throughout the year, so even if this one may not be right for you, we Read More
Anticipated Release Date: Q3FY26 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous Read More
Anticipated Release: Q4FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in the Countering Weapons of Mass Destruction (CWMD) Consortium. This Consortium releases numerous solicitations throughout the year, so even Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2026 - All rights reserved.